T1	p 83 92	cessation
T2	p 715 812	PARTICIPANTS A total of 403 adult , daily smokers without contraindications to bupropion SR use .
T3	i 33 70	bupropion sustained-release treatment
T4	i 174 208	bupropion sustained-release ( SR )
T5	i 455 464	bupropion
T6	i 550 568	placebo-controlled
T7	i 587 599	bupropion SR
T8	i 794 806	bupropion SR
T9	i 875 924	9-week course of bupropion SR or placebo pill and
T10	i 942 997	brief individual counseling sessions or no counseling .
T11	i 1118 1127	post-quit
T12	i 1161 1169	equation
T13	i 1237 1259	bupropion SR treatment
T14	i 1487 1496	Bupropion
T15	i 1696 1708	bupropion SR
T16	o 326 411	distress , cigarette craving , positive affect and subjective reactions to cigarettes
T17	o 1011 1093	Ecological momentary assessment ratings of smoking behavior and putative mediators
T18	o 1303 1322	withdrawal distress
T19	o 1340 1358	subjective effects
T20	o 1438 1445	craving
T21	o 1485 1507	. Bupropion SR effects
T22	o 1511 1538	point-prevalence abstinence
T23	o 1601 1611	motivation